La Jolla Pharmaceutical Statistics Share Statistics La Jolla Pharmaceutical has 0
shares outstanding. The number of shares has increased by -6.97%
in one year.
Shares Outstanding n/a Shares Change (YoY) -6.97% Shares Change (QoQ) -7.15% Owned by Institutions (%) n/a Shares Floating 11.49M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 59.69K, so 0% of the outstanding
shares have been sold short.
Short Interest 59.69K Short % of Shares Out n/a Short % of Float 0.24% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 8.08 and the forward
PE ratio is null.
La Jolla Pharmaceutical's PEG ratio is
-0.06.
PE Ratio 8.08 Forward PE n/a PS Ratio 2.1 Forward PS n/a PB Ratio -2.38 P/FCF Ratio 5.63 PEG Ratio -0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for La Jolla Pharmaceutical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.82,
with a Debt / Equity ratio of -0.04.
Current Ratio 3.82 Quick Ratio 3.46 Debt / Equity -0.04 Debt / EBITDA 0.08 Debt / FCF 0.09 Interest Coverage 2.09
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.24M Profits Per Employee $322.3K Employee Count 61 Asset Turnover 0.75 Inventory Turnover 2.15
Taxes Income Tax 49K Effective Tax Rate 0.25%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 2.41, so La Jolla Pharmaceutical's
price volatility has been higher than the market average.
Beta 2.41 52-Week Price Change n/a 50-Day Moving Average 5.06 200-Day Moving Average n/a Relative Strength Index (RSI) 78.94 Average Volume (20 Days) n/a
Income Statement In the last 12 months, La Jolla Pharmaceutical had revenue of 75.72M
and earned 19.66M
in profits. Earnings per share was 0.58.
Revenue 75.72M Gross Profit 62.23M Operating Income 21.83M Net Income 19.66M EBITDA 32.05M EBIT 30.17M Earnings Per Share (EPS) 0.58
Full Income Statement Balance Sheet The company has 46.67M in cash and 2.64M in
debt, giving a net cash position of 44.02M.
Cash & Cash Equivalents 46.67M Total Debt 2.64M Net Cash 44.02M Retained Earnings -1.06B Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 28.24M
and capital expenditures -9K, giving a free cash flow of 28.23M.
Operating Cash Flow 28.24M Capital Expenditures -9K Free Cash Flow 28.23M FCF Per Share 0.83
Full Cash Flow Statement Margins Gross margin is 82.19%, with operating and profit margins of 28.83% and 25.96%.
Gross Margin 82.19% Operating Margin 28.83% Pretax Margin 26.03% Profit Margin 25.96% EBITDA Margin 42.32% EBIT Margin 28.83% FCF Margin 37.29%
Dividends & Yields LJPC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for LJPC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 14, 2014. It was a
backward
split with a ratio of 1:50.
Last Split Date Jan 14, 2014 Split Type backward Split Ratio 1:50
Scores Altman Z-Score n/a Piotroski F-Score n/a
